Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now shows the trial as Completed and adds a publication on HRQOL and symptom impact in CheckMate 9ER.
    Difference
    0.2%
    Check dated 2026-08-24T16:21:31.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a small editorial update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-10T10:26:03.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page’s documentation without changing the primary study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:20:45.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new publication citation about the final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma has been added to the Publications section. The document revision has been updated from v3.6.2 to v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-05T13:43:48.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Platform revision updated from v3.6.0 to v3.6.2, representing an underlying system update that does not affect the displayed study information.
    Difference
    0.0%
    Check dated 2026-06-28T08:30:15.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment is closed and no longer seeking participants. This reflects the current participation status in the study overview.
    Difference
    0.2%
    Check dated 2026-06-14T06:21:40.000Z thumbnail image

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.